Press Release | Newsroom | Medtronic | FDA Expands Clearance of Medtronic Implants for the Treatment of Snoring

Press Release

Printer Friendly Version View printer-friendly version
Download PDF Download PDF
<< Back
FDA Expands Clearance of Medtronic Implants for the Treatment of Snoring

New labeling means more patients can get relief from snoring

MINNEAPOLIS – July 11, 2012 – Medtronic, Inc. (NYSE: MDT) today announced that the FDA has cleared new labeling information for the Pillar Palatal Implant system which is used to help reduce the severity of snoring in patients. While the Medtronic device had been previously approved for the treatment of snoring and sleep apnea, this latest  approval allows ENT surgeons to use up to five Pillar Implants specifically for snoring - good news for patients with wider mouths and softer palate tissue.

“The National Sleep Foundation estimates that nearly 90 million American adults are affected by snoring,” said Janis Saunier, marketing director for the Surgical Technologies division at Medtronic, Inc.  ”We’re pleased that we can now offer the Pillar Procedure to patients who previously were not candidates.”

This new labeling will allow surgeons to utilize more implants per snoring procedure if it is determined that the patient will have a superior benefit.  While FDA has cleared the use of up to five implants for the treatment of snoring, the use of more than three implants for the treatment of mild to moderate obstructive sleep apnea has not yet been studied and is not cleared for use by the FDA.

About The Pillar Procedure
The Pillar® Procedure is a method for stiffening the soft palate to address tissue vibration and collapse that can block the upper airway and contribute to snoring and OSA.  A specially trained ENT doctor or oral maxillofacial surgeon places the small implants into the soft palate, using a special delivery tool. Over time, the implants work with the body's natural response, which causes tissue around the implants to anchor, encapsulate, and connect them — adding structural support to stiffen the soft palate. This structural support helps to reduce the tissue vibration that can cause snoring.
For more information, visit

About Medtronic Surgical Technologies
The Surgical Technologies business develops products and procedural solutions for neurosurgery, spinal & orthopedic surgery, as well as ENT.  This includes solutions for the diagnosis and treatment of chronic diseases and disorders of the ear, nose and throat; surgical devices and implantable products for the treatment of cranial, spinal and specialty small-bone conditions; and advanced navigation and imaging solutions used in operating rooms.

About Medtronic
Medtronic, Inc. (, headquartered in Minneapolis, is the global leader in medical technology – alleviating pain, restoring health, and extending life for millions of people around the world.

Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic’s periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.

– end –

Medtronic Media Contacts:
Amy von Walter, Public Relations, 763-505-3780
Jeff Warren, Investor Relations, 763-505-2696